372 related articles for article (PubMed ID: 38473812)
1. Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion.
De Fazio E; Pittarello M; Gans A; Ghosh B; Slika H; Alimonti P; Tyler B
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473812
[TBL] [Abstract][Full Text] [Related]
2. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment.
Silver DJ; Siebzehnrubl FA; Schildts MJ; Yachnis AT; Smith GM; Smith AA; Scheffler B; Reynolds BA; Silver J; Steindler DA
J Neurosci; 2013 Sep; 33(39):15603-17. PubMed ID: 24068827
[TBL] [Abstract][Full Text] [Related]
4. Tumor Cell Invasion in Glioblastoma.
Vollmann-Zwerenz A; Leidgens V; Feliciello G; Klein CA; Hau P
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178267
[TBL] [Abstract][Full Text] [Related]
5. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
6. Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma.
Kim Y; Kang H; Powathil G; Kim H; Trucu D; Lee W; Lawler S; Chaplain M
PLoS One; 2018; 13(10):e0204865. PubMed ID: 30286133
[TBL] [Abstract][Full Text] [Related]
7. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
8. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling.
Kim JK; Jin X; Sohn YW; Jin X; Jeon HY; Kim EJ; Ham SW; Jeon HM; Chang SY; Oh SY; Yin J; Kim SH; Park JB; Nakano I; Kim H
Cancer Lett; 2014 Oct; 353(2):194-200. PubMed ID: 25079688
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles in Glioblastoma Tumor Microenvironment.
Yekula A; Yekula A; Muralidharan K; Kang K; Carter BS; Balaj L
Front Immunol; 2019; 10():3137. PubMed ID: 32038644
[TBL] [Abstract][Full Text] [Related]
10. Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.
Okolie O; Bago JR; Schmid RS; Irvin DM; Bash RE; Miller CR; Hingtgen SD
Neuro Oncol; 2016 Dec; 18(12):1622-1633. PubMed ID: 27298311
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
Zhang H; Zhou Y; Cui B; Liu Z; Shen H
Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060
[TBL] [Abstract][Full Text] [Related]
12. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
13. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma.
Rorive S; Belot N; Decaestecker C; Lefranc F; Gordower L; Micik S; Maurage CA; Kaltner H; Ruchoux MM; Danguy A; Gabius HJ; Salmon I; Kiss R; Camby I
Glia; 2001 Mar; 33(3):241-55. PubMed ID: 11241742
[TBL] [Abstract][Full Text] [Related]
14. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
[TBL] [Abstract][Full Text] [Related]
15. Investigating the Interactions of Glioma Stem Cells in the Perivascular Niche at Single-Cell Resolution using a Microfluidic Tumor Microenvironment Model.
Adjei-Sowah EA; O'Connor SA; Veldhuizen J; Lo Cascio C; Plaisier C; Mehta S; Nikkhah M
Adv Sci (Weinh); 2022 Jul; 9(21):e2201436. PubMed ID: 35619544
[TBL] [Abstract][Full Text] [Related]
16. Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.
Dhruv HD; Roos A; Tomboc PJ; Tuncali S; Chavez A; Mathews I; Berens ME; Loftus JC; Tran NL
J Neurooncol; 2016 Feb; 126(3):397-404. PubMed ID: 26559543
[TBL] [Abstract][Full Text] [Related]
17. Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion.
Xu Y; Zhang L; Wei Y; Zhang X; Xu R; Han M; Huang B; Chen A; Li W; Zhang Q; Li G; Wang J; Zhao P; Li X
Oncotarget; 2017 Apr; 8(14):23401-23413. PubMed ID: 28423580
[TBL] [Abstract][Full Text] [Related]
18. STAT6 expression in glioblastoma promotes invasive growth.
Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
[TBL] [Abstract][Full Text] [Related]
19. Tumor Cell Invasion and the Tumor Microenvironment: Special Focus on Brain Tumors.
Daubon T; Magaut R; Bikfalvi A
Adv Exp Med Biol; 2021; 1329():109-121. PubMed ID: 34664236
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment.
Nandhu MS; Kwiatkowska A; Bhaskaran V; Hayes J; Hu B; Viapiano MS
Oncogene; 2017 Aug; 36(34):4875-4886. PubMed ID: 28414309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]